Evidence map›Paper›PMID 38893554›Full record

ArticleMolecules (Basel, Switzerland)2024

Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning.

Lu Zhao, Jian Wang, Wanchun Yang, Kunpeng Zhao, Qingtao Sun, Jianzhong Chen

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Identifying Inhibitor-SARS-CoV2-3CLMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lu ZhaoSchool of Science, Shandong Jiaotong University, Jinan 250357, China.
Jian WangSchool of Science, Shandong Jiaotong University, Jinan 250357, China.ORCID 0009-0009-8635-3635
Wanchun YangSchool of Science, Shandong Jiaotong University, Jinan 250357, China.ORCID 0009-0004-0899-123X
Kunpeng ZhaoSchool of Science, Shandong Jiaotong University, Jinan 250357, China.
Qingtao SunSchool of Science, Shandong Jiaotong University, Jinan 250357, China.
Jianzhong ChenSchool of Science, Shandong Jiaotong University, Jinan 250357, China.ORCID 0000-0003-1558-4398

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CDK6 plays a key role in the regulation of the cell cycle and is considered a crucial target for cancer therapy. In this work, conformational transitions of CDK6 were identified by using Gaussian accelerated molecular dynamics (GaMD), deep learning (DL), and free energy landscapes (FELs). DL finds that the binding pocket as well as the T-loop binding to the Vcyclin protein are involved in obvious differences of conformation contacts. This result suggests that the binding pocket of inhibitors (LQQ and AP9) and the binding interface of CDK6 to the Vcyclin protein play a key role in the function of CDK6. The analyses of FELs reveal that the binding pocket and the T-loop of CDK6 have disordered states. The results from principal component analysis (PCA) indicate that the binding of the Vcyclin protein affects the fluctuation behavior of the T-loop in CDK6. Our QM/MM-GBSA calculations suggest that the binding ability of LQQ to CDK6 is stronger than AP9 with or without the binding of the Vcyclin protein. Interaction networks of inhibitors with CDK6 were analyzed and the results reveal that LQQ contributes more hydrogen binding interactions (HBIs) and hot interaction spots with CDK6. In addition, the binding pocket endures flexibility changes from opening to closing states and the Vcyclin protein plays an important role in the stabilizing conformation of the T-loop. We anticipate that this work could provide useful information for further understanding the function of CDK6 and developing new promising inhibitors targeting CDK6.

Indexed as

Cyclin-Dependent Kinase 6Deep LearningMolecular Dynamics SimulationProtein BindingBinding SitesHumansNormal DistributionPrincipal Component AnalysisProtein ConformationProtein Kinase InhibitorsThermodynamicsCDK6 protein, humanCyclin-Dependent Kinase 6Protein Kinase InhibitorsCDK6deep learningfree energy landscapegaussian accelerated dynamics simulations

Identifiers

PMID38893554
PMCPMC11174096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.